Platelet characteristics in patients with essential thrombocytosisOliver Buchhave Pedersen, Anne‐Mette Hvas, Erik Lerkevang Grove et al.|Cytometry Part B Clinical Cytometry|2018Cited by 46
Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemiaJenny Q. D. Tran, Peter H. Nissen, Erik Lerkevang Grove et al.|Platelets|2019Cited by 31
Once- versus twice-daily aspirin treatment in patients with essential thrombocytosisMads Lamm Larsen, Erik Lerkevang Grove, Peter Buur van Kooten Niekerk et al.|Platelets|2018Cited by 16
Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet TurnoverErik Lerkevang Grove, Mads Lamm Larsen, Anne‐Mette Hvas et al.|American Journal of Case Reports|2017Cited by 12
Benefits and Harm of Treatment with P2Y12 Inhibitors beyond 12 Months in Patients with Coronary Artery DiseaseMads Lamm Larsen, Anne‐Mette Hvas, Erik Lerkevang Grove et al.|Seminars in Thrombosis and Hemostasis|2019Cited by 1